BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 | The Kingston Whig Standard
FY 2023 Revenue Increased 2.3x to $12.7 Million USDThe Company expects Q1 2024 Revenue to be in the range of $5.2 million to $5.3 million
Stay updated with breaking news from A Contract Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FY 2023 Revenue Increased 2.3x to $12.7 Million USDThe Company expects Q1 2024 Revenue to be in the range of $5.2 million to $5.3 million
Agreement would result in Sharps and Roncadelle Joining Forces to Access Global Healthcare Organizations Through More Than 30 Sales Partners worldwide...
LISBON, Portugal, Nov. 16, 2023 /PRNewswire/ -- Hovione, the specialist integrated CDMO and the leader in...
/PRNewswire/ -- Hovione, the specialist integrated CDMO and the leader in spray drying and particle engineering, today announced it has acquired ExtremoChem...
Hovione, the specialist integrated CDMO and the leader in spray drying and particle engineering, today announced it has acquired ExtremoChem Lda (ExtremoChem), an innovative start-up company focused on the synthesis, development, and commercialization of bio-inspired synthetic sugars, targeting enhanced stabilization, reduced viscosity and delivery performance of proteins and other biopharmaceuticals.